Phillip B. Maples

3.3k citations

37 papers · 2.1k indexed · h-index 20

Impact in

Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Biotechnology top 2%
- Cancer Research and Treatments

Papers in

Biotechnology 10
- Cancer Research and Treatments 10
Genetics 7
- Virus-based gene therapy research 9

Co-authors: John Nemunaitis Neil Senzer Beena O. Pappen David H. Kirn Britta Randlev Casey Cunningham Padmasini Kumar Shushan Rana
Journals: Cancer Gene Therapy (5 papers)Molecular Therapy (3 papers)Developmental Biology (3 papers)Journal of Clinical Oncology (2 papers)Gene Therapy (2 papers)
Partner nations: United States Germany Japan

In The Last Decade

Phillip B. Maples

37 papers receiving 2.1k citations

Peers

Countries citing papers authored by Phillip B. Maples

Since Specialization

Citations

This map shows the geographic impact of Phillip B. Maples's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip B. Maples with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip B. Maples more than expected).

Fields of papers citing papers by Phillip B. Maples

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip B. Maples. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip B. Maples. The network helps show where Phillip B. Maples may publish in the future.

Co-authors

The 25 scholars most cited alongside Phillip B. Maples, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Phillip B. Maples Line = papers co-authored together Phillip B. Maples links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform Cancer Gene Therapy ·James X. Wu, В Б Зваридчук, Jiyang Yu, Guisheng Zhou, Marcelo Luís Schwab, Chris Jay, Padmasini Kumar, 王贤, N S Templeton, Neil Senzer, Phillip B. Maples, John Nemunaitis, F. Charles Brunicardi	2014	16
2	Summary of bi-shRNA<sup>furin</sup>/GM-CSF Augmented Autologous Tumor Cell Immunotherapy (FANG™) in Advanced Cancer of the Liver Oncology ·John Nemunaitis, Minal Barve, Douglas Orr, Joseph A. Kuhn, Mitchell J. Magee, Alexey G. Kvasov, Cynthia Bedell, Gladice Wallraven, Beena O. Pappen, 丁小燕, Staci Horvath, Ae Joo Lee, Padmasini Kumar, Phillip B. Maples, Neil Senzer	2014	41
3	Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine Gene Therapy ·John Nemunaitis, Neil Senzer, Natasha Simpson, Padmasini Kumar, Minal Barve, Joseph A. Kuhn, H.H. Andersen, Mitchell J. Magee, Yang Yu, Gladice Wallraven, Beena O. Pappen, Phillip B. Maples	2013	7
4	FANG Vaccine: Autologous Tumor Cell Vaccine Genetically Modified to Express GM-CSF and Block Production of Furin BioProcessing Journal ·Phillip B. Maples, Padmasini Kumar, Yang Yu, Zhaohui Wang, Chris Jay, Beena O. Pappen, Marcelo Luís Schwab, Joseph A. Kuhn, John Nemunaitis, Neil Senzer	2010	24
5	Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference Cancer Gene Therapy ·Donald D. Rao, Phillip B. Maples, Neil Senzer, Padmasini Kumar, Zheng‐Liang Wang, Beena O. Pappen, Yang Yu, Lisa Reynolds, Chris Jay, Anagha P. Phadke, S Chen, Joseph A. Kuhn, Sidi Mohamed Kasmi, Nicolas Tittley, David J. Monsma, Craig P. Webb, Akash Ambashankar, 何勤勇, John Nemunaitis	2010	36
6	Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapy The Journal of Gene Medicine ·Gregory Nemunaitis, Phillip B. Maples, Chris Jay, William A. Gahl, Marjan Huizing, Justin Poling, Alex W. Tong, Anagha P. Phadke, Beena O. Pappen, Cynthia Bedell, Nancy Smyth Templeton, Joseph A. Kuhn, Neil Senzer, John Nemunaitis	2010	19
7	A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors Molecular Therapy ·John Nemunaitis, Alex W. Tong, Michael Nemunaitis, Neil Senzer, Anagha P. Phadke, Cynthia Bedell, Ned Adams, Yu‐An Zhang, Phillip B. Maples, 竜暁藤本, Beena O. Pappen, James M. Burke, Rajnish Patidar, Yasuo Urata, Toshiyoshi Fujiwara	2009	205
8	Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients Cancer Gene Therapy ·John Nemunaitis, Michael Nemunaitis, Neil Senzer, М.А. Нурова, Cindi Bedell, Padmasini Kumar, Beena O. Pappen, Phillip B. Maples, Daniel L. Shawler, Habib Fakhrai	2009	116
9	Systemic Therapeutic Gene Delivery for Cancer: Crafting Paris Arrow Current Gene Therapy ·Alex Tong, Chris Jay, Neil Senzer, Phillip B. Maples, John Nemunaitis	2009	41
10	Hereditary Inclusion Body Myopathy (HIBM2) PubMed ·Chris Jay, 近藤絵里, Gregory Nemunaitis, Phillip B. Maples, John Nemunaitis	2009	12
11	Induction of Immune Responses and Clinical Efficacy in a Phase II Trial of IDM-2101, a 10-Epitope Cytotoxic T-Lymphocyte Vaccine, in Metastatic Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Minal Barve, James Bender, Neil Senzer, Casey Cunningham, F. Anthony Greco, Billie Falgout, Ronald G. Steis, Hung T. Khong, Donald Richards, Joe Stephenson, K.V. Gushchin, M DEALDA, Glenn Ishioka, Beena O. Pappen, Michael Nemunaitis, Michael A. Morse, Bonnie Mills, Phillip B. Maples, 正智小王, John Nemunaitis	2008	70
12	Proof concept for clinical justification of network mapping for personalized cancer therapeutics Cancer Gene Therapy ·John Nemunaitis, Neil Senzer, Iya Khalil, Yuqiao Shen, Pardeep Kumar, Aiping Tong, Joseph A. Kuhn, Jeffrey P. Lamont, Michael Nemunaitis, Marcelo Luís Schwab, Ya Zhang, Yongning Zhou, John S. Vorhies, Phillip B. Maples, Colin Hill, D. Shanahan	2007	13
13	Granulocyte-Macrophage Colony-Stimulating Factor Gene-Modified Autologous Tumor Vaccines in Non-Small-Cell Lung Cancer JNCI Journal of the National Cancer Institute ·John Nemunaitis, ロバート・Z ローレンス, David M. Jablons, Joseph Wayne Smith, Bernard A. Fox, Phillip B. Maples, Stephanie Hamilton, Flavia Borellini, Ann Lin, Gaurav P. Khandhar, Kristen Hege	2004	182
14	Potential Clinical Application of Antioncogene Ribozymes for Human Lung Cancer Clinical Lung Cancer ·Alex W. Tong, Yuan Zhang, Casey Cunningham, Phillip B. Maples, John Nemunaitis	2001	8
15	Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity Gene Therapy ·John Nemunaitis, Casey Cunningham, O Obeysekera, Zhuoqing Zhang, Gerald M. Edelman, Phillip B. Maples, George J. Netto, Akash Ambashankar, Britta Randlev, S.C. Olson, David H. Kirn	2001	228
16	Cellular Immune Profile of Patients With Advanced Cancer Before and After Taxane Treatment American Journal of Clinical Oncology ·A W Tong, O. N. Tkacheva, Jennifer Lawson, Graciela Ordóñez, Svetislava J. Vukelja, William Hyman, Donald Richards, Lincoln Stein, Phillip B. Maples, John Nemunaitis	2000	48
17	A Closed Culture System for the Ex Vivo Transduction and Expansion of Human T Lymphocytes Journal of Hematotherapy ·Éric Robinet, F.S. Kauark, Christophe Ferrand, Phillip B. Maples, S. V. Dmitrieva, Jean‐Yves Cahn, Craig W. Reynolds, MARIBEL VALVERDE RAMIREZ, Patrick Hervé, Pierre Tiberghien	1998	30
18	Differential Expression of α- and β-Globin Genes in Erythroleukemic Cell Lines Molecular and Cellular Biology ·Nega Beru, Phillip B. Maples, Olivier Hermine, Eugene Goldwasser	1990	1
19	Determination of hemoglobin expression patterns in erythroid cells of Rana catesbeiana tadpoles Comparative Biochemistry and Physiology Part B Comparative Biochemistry ·Phillip B. Maples, Bill Pinkston, Robert H. Broyles	1988	4
20	In vivo regulation of hemoglobin phenotypes of developing Rana catesbeiana Developmental Biology ·Phillip B. Maples, Bill Pinkston, Robert H. Broyles	1986	7

About Phillip B. Maples

Phillip B. Maples is a scholar working on Biotechnology, Genetics, Oncology, Immunology and Genetics, having authored 37 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Research and Treatments (10 papers), Virus-based gene therapy research (9 papers), Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (6 papers), Inflammatory Myopathies and Dermatomyositis (6 papers), CAR-T cell therapy research (5 papers), Erythrocyte Function and Pathophysiology (5 papers) and Muscle Physiology and Disorders (5 papers). The work is most often cited by research in Oncology (1.2k citations), Biotechnology (329 citations), Genetics (853 citations), Immunology (591 citations) and Molecular Biology (1.1k citations). Phillip B. Maples has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include John Nemunaitis, Neil Senzer, Beena O. Pappen, David H. Kirn, Britta Randlev, Casey Cunningham, Padmasini Kumar, Shushan Rana, Alex Tong and Michael Nemunaitis. Their work appears in journals such as Cancer Gene Therapy, Molecular Therapy, Developmental Biology, Journal of Clinical Oncology and Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact